← Eichor
Study identifier: NCT06192953 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Early Functional Proprioceptive Stimulation Post-stroke

Condition: Stroke (CVA) or TIA  ·  Sponsor: Centre Hospitalier Universitaire de Nice

PhaseNA
Planned participants32
Who can joinAll sexes, 18 Years to 100 Years
Healthy volunteersNo

About this study

The main objective of our study is to evaluate the impact of the use of Functional Proprioceptive Stimulation (FPS) on the recovery of the postural and motor functional capacities of the patient in the subacute phase of a stroke. The hypothesis is that the use of FPS has a positive impact on the recovery of the patient's functional abilities, as well as on the duration of treatment until the sit/stand transfers are completed. To evaluate this potential effect,there will be a randomization with two groups : one will have 5 sessions a week for 6 weeks maximum of SPF and the other groupe will have the same sessions but with the device stettled but not activated.

This description comes directly from the study's public registry record.

Talk to the study team

Guillaume SACCO, MD  ·  04 92 03 47 51  ·  sacco.g@chu-nice.fr

Justine LEMAIRE  ·  +33492034778  ·  lemaire.j@chu-nice.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHU de NiceNice, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06192953